Published in Clin Exp Rheumatol on March 29, 2010
Adult-onset Still disease: a rare disorder with a potentially fatal outcome. Auto Immun Highlights (2010) 0.82
Clinical features and prognosis of adult-onset Still's disease: 75 cases from China. Int J Clin Exp Med (2015) 0.76
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients. Clin Rheumatol (2016) 0.76
Periodontal infection in adult-onset Still's disease patient: clinical and haematological considerations. BMJ Case Rep (2011) 0.75
Epidemiological study of adult-onset Still's disease using a Japanese administrative database. Rheumatol Int (2016) 0.75
Successful eradication of sexually transmitted diseases in the People's Republic of China: implications for the 21st century. J Infect Dis (1996) 2.72
Takayasu's arteritis: A study of 104 Italian patients. Arthritis Rheum (2005) 1.94
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) (2002) 1.61
The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood (2000) 1.58
Thymoma associated with systemic lupus erythematosus and immunologic abnormalities. Lupus (2000) 1.53
PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum (2001) 1.37
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2005) 1.37
Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin Cancer Res (1998) 1.29
Restriction endonuclease mapping of the root-inducing plasmid of Agrobacterium rhizogenes 1855. Plasmid (1983) 1.20
Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti-beta2-glycoprotein I antibodies. Arthritis Rheum (1999) 1.19
Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies. Arthritis Rheum (1998) 1.17
Meningeal involvement in Wegener's granulomatosis is associated with localized disease. Clin Exp Rheumatol (2006) 1.10
Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo. Oncogene (2000) 1.07
Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity. Arthritis Rheum (2000) 1.03
Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies. J Intern Med (2004) 0.99
Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein I antibodies. J Autoimmun (1998) 0.98
Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis. Clin Exp Immunol (2009) 0.95
Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I. Arthritis Rheum (1998) 0.94
Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model. Cancer Res (2000) 0.93
Daudi lymphoma killing triggers the programmed death of cytotoxic V gamma 9/V delta 2 T lymphocytes. J Immunol (1995) 0.90
Efficacy and safety of biological agents in adult-onset Still's disease. Scand J Rheumatol (2015) 0.88
Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells. J Leukoc Biol (1999) 0.86
Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum. Clin Exp Immunol (2014) 0.86
Engagement of CD30 shapes the secretion of cytokines by human gamma delta T cells. Eur J Immunol (2000) 0.86
Giant condyloma acuminatum quickly growing: case report. G Chir (2012) 0.85
Risk factors for Sjögren's syndrome: a case-control study. Clin Exp Rheumatol (2007) 0.85
Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5' regulatory region. Genes Immun (2002) 0.83
Antinuclear antibodies in progressive systemic sclerosis. Clin Exp Rheumatol (1985) 0.83
Relationship of lupus anticoagulant, anticardiolipin, anti-beta2-GPI and anti-prothrombin autoantibodies with history of thrombosis in patients with the clinical suspicion of APA-syndrome. Thromb Haemost (1997) 0.82
Contamination of Italian citrus essential oils: presence of phthalate esters. J Agric Food Chem (1999) 0.82
[Wegener's granulomatosis: an analysis of 50 patients]. Reumatismo (2005) 0.81
High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment. Ann Rheum Dis (2009) 0.80
Anti-beta2 glycoprotein I antibodies prevent the De-activation of platelets and sustain their phagocytic clearance. J Autoimmun (2000) 0.80
Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. J Rheumatol (1997) 0.80
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clin Exp Rheumatol (1999) 0.79
CD95 engagement releases calcium from intracellular stores of long term activated, apoptosis-prone gammadelta T cells. J Immunol (1996) 0.79
The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes. Cancer Res (1997) 0.78
Production and characterization of monoclonal antibodies directed against the laminin receptor precursor. Int J Biol Markers (1997) 0.77
Budd-Chiari syndrome in a patient with ulcerative colitis: association with anticardiolipin antibodies. J Clin Gastroenterol (2000) 0.77
Inhibition of caspases maintains the antineoplastic function of gammadelta T cells repeatedly challenged with lymphoma cells. Cancer Res (2001) 0.77
A case of palpebral dirofilariasis. Eur J Ophthalmol (2005) 0.77
Interleukin 2 and mitogen driven proliferation in human peripheral mononuclear cells: a kinetic analysis. Haematologica (1989) 0.77
Berger's disease with polyarteritis nodosa. Br J Rheumatol (1989) 0.77
Production of a monoclonal antibody directed against the high-affinity nerve growth factor receptor. Int J Biol Markers (1999) 0.76
Statistical study of the influence of fungicide treatments (mancozeb, zoxamide and copper oxychloride) on heavy metal concentrations in Sicilian red wine. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2008) 0.76
Two cases of meningeal involvement in Wegener's granulomatosis. Rheumatology (Oxford) (2004) 0.76
Miliary tuberculosis after biological therapy for rheumatoid arthritis. Rheumatology (Oxford) (2002) 0.76
Immune function and renal transplantation in Fabry's disease. Proc Eur Dial Transplant Assoc Eur Ren Assoc (1985) 0.76
Letter: Unblocking of T lymphocytes. Lancet (1975) 0.76
Takayasu's arteritis: therapeutic strategies. J Nephrol (2002) 0.75
Use and safety profile of antiepileptic drugs in Italy. Eur J Clin Pharmacol (2007) 0.75
Neurological involvement in rheumatological diseases. Neurol Sci (2005) 0.75
Anti-beta2 glycoprotein I antibodies cause inflammation and recruit dendritic cells in platelet clearance. Thromb Haemost (2001) 0.75
NSAIDs discontinuation and myocardial infarction. J Thromb Haemost (2009) 0.75
Hypertension negatively affects the pregnancy outcome in patients with antiphospholipid syndrome. Lupus (2012) 0.75
Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL). Clin Exp Immunol (1990) 0.75
AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens. Clin Exp Immunol (1986) 0.75
Autoimmune thyroiditis following interleukin-2 and LAK cell therapy for metastatic renal cell carcinoma: correlation with tumor regression. Tumori (1991) 0.75
Two novel monoclonal antibodies against the MUC4 tandem repeat reacting with an antigen overexpressed by lung cancer. Int J Biol Markers (2001) 0.75
Propionibacterium acnes sepsis in a previously healthy man. Clin Infect Dis (1998) 0.75
Adenosine induced production of a soluble factor affecting lymphocyte activation. Immunol Lett (1986) 0.75
[Use of calcium carbonate as an intestinal chelator of phosphorus]. Minerva Urol Nefrol (1990) 0.75
V delta 1+ gamma/delta T lymphocytes infiltrating human lung cancer express the CD8 alpha/alpha homodimer. Scand J Immunol (1994) 0.75
Organochlorine pesticide residues in Italian citrus essential oils, 1991-1996. J Agric Food Chem (2000) 0.75
Danazol suppresses both spontaneous and activated human lymphocyte-mediated cytotoxicity. Am J Reprod Immunol (1992) 0.75
Production of a novel monoclonal antibody against MUC4 mucin. Int J Biol Markers (1997) 0.75
Thymopentine treatment improves clinical and immunological functions in aged subjects with chronic bronchitis. Boll Ist Sieroter Milan (1987) 0.75
Pancreatic involvement in Legionella pneumonia. Infection (2015) 0.75
Age-related changes in interleukin 2 responsiveness of resting and activated human mononuclear cells. Haematologica (1991) 0.75
Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A. Rheumatology (Oxford) (2000) 0.75
[Validity of contact thermography in breast diagnosis]. Minerva Med (1980) 0.75
[Mortality and hospital complications of the myocardial infarction after dismissal from the coronary care unit (author's transl)]. G Ital Cardiol (1980) 0.75
Serum factors influencing spontaneous rosette formation by lymphocytes of pregnant women. Am J Obstet Gynecol (1977) 0.75
Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma. Ann Hematol (2002) 0.75
Aortic valve replacement in Cogan's syndrome. Eur J Cardiothorac Surg (1991) 0.75
[Current findings in progressive systemic sclerosis]. Minerva Med (1982) 0.75
Unusual bleeding manifestations in a case of primary amyloidosis with factor X deficiency but elevations of in vivo markers of thrombin formation and activity. Thromb Res (1995) 0.75
Apoptosis and systemic autoimmunity: the dendritic cell connection. Eur J Histochem (2000) 0.75
Immunogenetics of Lennox-Gastaut syndrome: search for LD determinants as genetic markers of the syndrome. Boll Ist Sieroter Milan (1978) 0.75
[Esophageal motor changes in patients with Raynaud's phenomenon and suspected scleroderma. Electromanometric and serologic evaluations]. Minerva Med (1984) 0.75
[Treatment of vaginitis of diverse etiology with a new preparation derived from thiophene]. Clin Ter (1985) 0.75
Rate of desensitization to HL-A antibodies in phytohaemagglutinin (PHA) stimulated lymphocytes. Boll Ist Sieroter Milan (1974) 0.75
Evaluation of cytotoxic cell-target cell conjugates. Comparison between flow cytometric analysis and 51Cr binding assay. Haematologica (1990) 0.75
[Comparison between atenolol and verapamil in the treatment of unstable angina]. Recenti Prog Med (1985) 0.75
Multiple drug hypersensivity: insight into the underlying mechanism and correlation with autoimmune diseases. Eur Ann Allergy Clin Immunol (2009) 0.75
HLA-A3 linked C3 deficiency in multiple sclerosis. Boll Ist Sieroter Milan (1977) 0.75
In vitro effects of adenosine induced supernatants on human T lymphocyte functions. Haematologica (1987) 0.75
Immunochemical identification of antigens of Brucella melitensis by means of CRIE. Microbiologica (1987) 0.75